Autres langues Splash Beverage Group, Inc.

Actions

SBEV

US84862C4015

Boissons non alcoolisées

Marché Fermé - NYSE 22:00:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
0,4715 ^USD	+10,94%		+16,42%	-82,93%

21/08	Splash Beverage Group, Inc. changera son code mnémonique de SBEV à EDVA	CI
19/08	Splash Beverage Group, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

21/08	Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
21/08	Splash Beverage Group, Inc. will Change its Name to Endovia Health Sciences, Inc
21/08	Splash Beverage Group, Inc. will Change its Ticker to EDVA from SBEV
20/08	Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences
19/08	Splash Beverage Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
12/08	Splash Beverage to Rebrand as Endovia Health Sciences
12/08	Splash Beverage Group to Rebrand as Endovia Health Sciences
07/08	Splash Beverage Files Prospectus for Resale of Shares by Selling Stockholder
05/08	Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway
29/07	Splash Beverage Group Expands CannEpil Platform into Veterinary Therapeutics
29/07	Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program
14/07	Splash Beverage to Effect 1-for-4 Reverse Stock Split
14/07	Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation
09/07	Splash Beverage Gets NYSE American Compliance Plan Acceptance
09/07	Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation
09/07	Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation
07/07	Top Premarket Decliners
07/07	SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL
06/07	Splash Beverage Acquires Exclusive Global Rights for Epilepsy Therapy CannEpil
06/07	Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential
15/06	Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
12/06	Splash Beverage Group, Inc. Announces Appointment of Michael Bondurant as Chief Operating Officer, Effective June 8, 2026
12/06	Avicanna Inc. announced that it has received CAD 0.600002 million in funding from Splash Beverage Group, Inc. and other investors
05/06	Top Premarket Decliners
04/06	Top Premarket Gainers